Cite

HARVARD Citation

    Kim, M. et al. (n.d.). Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. British journal of dermatology. pp. 208-210. [Online]. 
  
Back to record